1. Home
  2. ARTL vs BTTR Comparison

ARTL vs BTTR Comparison

Compare ARTL & BTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • BTTR
  • Stock Information
  • Founded
  • ARTL 2011
  • BTTR 1986
  • Country
  • ARTL United States
  • BTTR United States
  • Employees
  • ARTL N/A
  • BTTR N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • BTTR Beverages (Production/Distribution)
  • Sector
  • ARTL Health Care
  • BTTR Consumer Staples
  • Exchange
  • ARTL Nasdaq
  • BTTR Nasdaq
  • Market Cap
  • ARTL 3.6M
  • BTTR 3.4M
  • IPO Year
  • ARTL N/A
  • BTTR N/A
  • Fundamental
  • Price
  • ARTL $0.95
  • BTTR $2.02
  • Analyst Decision
  • ARTL Strong Buy
  • BTTR Strong Buy
  • Analyst Count
  • ARTL 2
  • BTTR 1
  • Target Price
  • ARTL $5.50
  • BTTR $10.00
  • AVG Volume (30 Days)
  • ARTL 1.2M
  • BTTR 126.5K
  • Earning Date
  • ARTL 05-12-2025
  • BTTR 05-16-2025
  • Dividend Yield
  • ARTL N/A
  • BTTR N/A
  • EPS Growth
  • ARTL N/A
  • BTTR N/A
  • EPS
  • ARTL N/A
  • BTTR N/A
  • Revenue
  • ARTL N/A
  • BTTR $34,975,000.00
  • Revenue This Year
  • ARTL N/A
  • BTTR $629.09
  • Revenue Next Year
  • ARTL N/A
  • BTTR N/A
  • P/E Ratio
  • ARTL N/A
  • BTTR N/A
  • Revenue Growth
  • ARTL N/A
  • BTTR N/A
  • 52 Week Low
  • ARTL $0.82
  • BTTR $1.45
  • 52 Week High
  • ARTL $1.59
  • BTTR $9.16
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 50.27
  • BTTR 61.28
  • Support Level
  • ARTL $0.82
  • BTTR $1.73
  • Resistance Level
  • ARTL $1.40
  • BTTR $1.95
  • Average True Range (ATR)
  • ARTL 0.11
  • BTTR 0.21
  • MACD
  • ARTL 0.02
  • BTTR 0.03
  • Stochastic Oscillator
  • ARTL 23.10
  • BTTR 96.15

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

About BTTR Better Choice Company Inc.

Better Choice Co Inc is a pet health and wellness portfolio company, offering consumers a wide variety of recognized premium pet products and hemp-derived CBD supplements. Its portfolio includes kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. Its core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-GMO fruits and vegetables. Its core products sold under the TruDog brand are made according to nutritional philosophy of fresh, meat-based nutrition and minimal processing.

Share on Social Networks: